Matthew Rosenberg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthew Rosenberg

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Therapeutic Innovation & Regulatory Science|June 5, 2020

Factors that have an Impact on Abbreviated New Drug Application (ANDA) SubmissionsSaranrat Wittayanukorn, Matthew Rosenberg, Andreas Schick, et al.

Plos One|December 17, 2014

Optimized brain extraction for pathological brains (optiBET)Evan S Lutkenhoff, Matthew Rosenberg, Jeffrey Chiang, et al.

Addictive Behaviors|February 10, 2020

The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiationCarolyn Wolff, William N Dowd, Mir M Ali, et al.

Clinical Pharmacology and Therapeutics|April 23, 2019

Predictive Analysis of First Abbreviated New Drug Application Submission for New Chemical Entities Based on Machine Learning MethodologyMeng Hu, Andrew Babiskin, Saranrat Wittayanukorn, et al.

Neuroimage|December 3, 2014

Optogenetic fMRI reveals distinct, frequency-dependent networks recruited by dorsal and intermediate hippocampus stimulationsAndrew J Weitz, Zhongnan Fang, Hyun Joo Lee, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Therapeutic Innovation & Regulatory Science|June 5, 2020

Factors that have an Impact on Abbreviated New Drug Application (ANDA) SubmissionsSaranrat Wittayanukorn, Matthew Rosenberg, Andreas Schick, et al.

Plos One|December 17, 2014

Optimized brain extraction for pathological brains (optiBET)Evan S Lutkenhoff, Matthew Rosenberg, Jeffrey Chiang, et al.

Addictive Behaviors|February 10, 2020

The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiationCarolyn Wolff, William N Dowd, Mir M Ali, et al.

Clinical Pharmacology and Therapeutics|April 23, 2019

Predictive Analysis of First Abbreviated New Drug Application Submission for New Chemical Entities Based on Machine Learning MethodologyMeng Hu, Andrew Babiskin, Saranrat Wittayanukorn, et al.

Neuroimage|December 3, 2014

Optogenetic fMRI reveals distinct, frequency-dependent networks recruited by dorsal and intermediate hippocampus stimulationsAndrew J Weitz, Zhongnan Fang, Hyun Joo Lee, et al.

Pageof 2